Aethlon Medical advances to final trial cohort after safety review
Tweet Send to a Friend
Aethlon Medical, Inc. (NASDAQ: AEMD) announced that an independent Data Safety Monitoring Board has approved advancement to the third and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


